Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 
Asian Currencies Hold Steady Amid U.S.-Israel-Iran Tensions and BOJ Signals 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
Oil Prices Dip as Trump Eyes Iran De-escalation, Hormuz Closure Persists 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Dollar Surges to Nine-Month High as Middle East Tensions Drive Safe-Haven Demand 
Australia Bans Card Payment Surcharges Starting October 2025 
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 
China Manufacturing PMI Hits 12-Month High Amid Energy Price Concerns 
Bank of Korea Nominee Shin Hyun-song Calls for Flexible Monetary Policy Amid Iran War Risks 
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn 
Gold Prices Rebound in Asia Amid Iran War Ceasefire Hopes 
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 
Canada's Economy Grows Modestly in January 2025, Driven by Energy and Construction 
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 
Lotte Biologics unveiled a landmark $3 billion partnership with Incheon's city government, Lotte Corporation, and Incheon Free Economic Zone (IFEZ) to establish major biotech production plants in Songdo. This monumental move accelerates the biotech giant's ambitious aim of a combined production capacity of 360,000 liters by 2030.
Lotte Biologics said on Tuesday, June 20, that the MOU is its first step into building the facilities in the region. As per Korea Joongang Daily, the other parties in the project are Lotte Corporation and the Incheon Free Economic Zone (IFEZ).
The contract signing ceremony was held at the IFEZ HQ in Songdo, and executives of the companies were present, including Lotte Biologics’ CEO, Richard Lee; IFEZ’s commissioner, Kim Jin Young; Lotte Corp. president, Lee Hun Ki; and Mayor of Incheon Metropolitan City, Yoo Jeong Bok.
The construction of the production facilities is part of the biotech firm’s plan to erect three new factories that will have a combined production facility of 360,000 liters by the year 2030. The plan was first unveiled in January this year.
The industrial complex will also be a place where the start-up, Bio-Venture Initiative, is expected to open a plant and facilitate possible technological cooperation. Lotte Biologics is planning a groundbreaking event for the construction, and this may happen soon.
This agreement highlights the enthusiastic response from Incheon Metropolitan City and Incheon Free Economic Zone regarding LOTTE BIOLOGICS’ intention to establish a major presence in Songdo,” Lotte Biologic’s chief executive officer said in a press release. “With the goal of commencing construction on the Mega Plant within the year, LOTTE BIOLOGICS will actively cooperate with Incheon Metropolitan City and Incheon Free Economic Zone to swiftly facilitate a land purchase agreement, with the enthusiastic support of LOTTE Corporation.”
Photo by: Lotte Biologics Newsroom
